spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

BioTrinity 2019

BIO Trinity 2019

30 April - 1 May 2019
etc.venues 155 Bishopsgate, London EC2M 3YD

BioTrinity 2019 is taking place from the 30thApril – 1st May at etc.venues 155 Bishopsgate in London. Now in its 13th year, BioTrinity remains the leading Life Sciences Biopartnering and Investment conference in Europe, and generates unrivalled opportunities for life science companies, academics, investors, and major pharmaceutical players to come together to do deals and establish collaborations.

BioTrinity 2019 incorporates significant improvements including a move to etc.venues 155 Bishopsgate, a central London location.  This new venue allows us to keep all activity on one floor which will focus the energy and facilitate interaction, thereby maximising visibility for our sponsors, exhibitors, BioLaunchPad® presenters and creating even more opportunities for networking and informal meetings.

The focus of the 2019 conference is to look at 'What’s new' in the industry, and we’ll be providing updates and insight on both technical and financial developments across a wide range of key therapeutics areas – have a look at the Draft Programme.

BioTrinity is developed and organised by OBN, the not-for-profit Membership organisation supporting and bringing together the life sciences industry, their corporate partners and investors.

Social Media:

Twitter - @biotrinity & @OBN_UK

LinkedIn - https://www.linkedin.com/company/1016463/

Website - http://www.biotrinity.com/

Contact:
OBN Events
events@obn.org.uk

phone +44 (0)1235 420870
email events@obn.org.uk
web www.biotrinity.com/
email London
 
Print this page
Send to a friend
   
spacer
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

White Papers

Clinical Trials in Russia Orange Paper: 1st Quarter 2014

Synergy Research Group

In summary, Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia: 1. Fast patient enrollment due to the centralized medical infrastructure. 2. Nearly 100% patient retention 3. GCP trained and certified Investigative Sites generating high quality data 4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >>


News and Press Releases

A new anti-tumour treatment is one step closer to the clinic thanks to a new collaboration between In3Bio and 3P Biopharmaceuticals

[Pamplona, November 26 2019] 3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has been chosen by In3Bio, a UK based Biotech company, to collaborate in the development of a novel anti-tumour treatment.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement